These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2689039)

  • 1. Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage.
    Meyers BR; Wilkinson P
    Clin Pharmacokinet; 1989 Dec; 17(6):385-95. PubMed ID: 2689039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.
    Mörike K; Schwab M; Klotz U
    Drugs Aging; 1997 Apr; 10(4):259-77. PubMed ID: 9108987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolones in the aged.
    Nicolle LE
    Drugs; 1999; 58 Suppl 2():49-51. PubMed ID: 10553705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly.
    Noreddin AM; Haynes V
    Drugs Aging; 2007; 24(4):275-92. PubMed ID: 17432923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly.
    Triggs E; Charles B
    Clin Pharmacokinet; 1999 Oct; 37(4):331-41. PubMed ID: 10554048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations.
    Lindsay CA; Bosso JA
    Clin Pharmacokinet; 1993 Jun; 24(6):496-506. PubMed ID: 8513651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
    Pea F; Viale P; Furlanut M
    Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.
    Bearden DT; Rodvold KA
    Clin Pharmacokinet; 2000 May; 38(5):415-26. PubMed ID: 10843460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of newer antibacterial agents in liver disease.
    Westphal JF; Brogard JM
    Clin Pharmacokinet; 1993 Jan; 24(1):46-58. PubMed ID: 8448972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum level monitoring of antibacterial drugs. A review.
    Wenk M; Vozeh S; Follath F
    Clin Pharmacokinet; 1984; 9(6):475-92. PubMed ID: 6391780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolone disposition in the elderly. Practical implications.
    Nilsson-Ehle I; Ljungberg B
    Drugs Aging; 1991; 1(4):279-88. PubMed ID: 1794020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuing education: alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patients.
    Winterboer TM; Lecci KA; Olsen KM
    J Pharm Pract; 2010 Feb; 23(1):6-18. PubMed ID: 21507788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.
    Lau AH; Lam NP; Piscitelli SC; Wilkes L; Danziger LH
    Clin Pharmacokinet; 1992 Nov; 23(5):328-64. PubMed ID: 1478003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolone pharmacokinetics in the elderly.
    Schentag JJ; Goss TF
    Am J Med; 1992 Apr; 92(4A):33S-37S. PubMed ID: 1316067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolones in the elderly.
    Bergan T
    Drugs; 1995; 49 Suppl 2():112-4. PubMed ID: 8549278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues.
    Williams DN; Raymond JL
    Clin Pharmacokinet; 1998 Jul; 35(1):65-77. PubMed ID: 9673835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and prescribing in the elderly.
    Swift CG
    J Antimicrob Chemother; 1994 Aug; 34 Suppl A():25-32. PubMed ID: 7844071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial dosing in obese patients.
    Wurtz R; Itokazu G; Rodvold K
    Clin Infect Dis; 1997 Jul; 25(1):112-8. PubMed ID: 9243045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.